• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Halogenated fatty acids

Comprehensive Overview of 2-Butenoic acid, 4,4-difluoro-3-methyl- (CAS No. 2169795-24-6): Properties, Applications, and Industry Trends

The chemical compound 2-Butenoic acid, 4,4-difluoro-3-methyl- (CAS No. 2169795-24-6) has garnered significant attention in recent years due to its unique structural features and versatile applications in pharmaceuticals, agrochemicals, and specialty materials. As a fluorinated derivative of butenoic acid, this compound exhibits enhanced stability and reactivity, making it a valuable intermediate in synthetic chemistry. Researchers and industry professionals are increasingly exploring its potential, particularly in the context of green chemistry and sustainable synthesis, which align with global trends toward environmentally friendly processes.

One of the most notable characteristics of 2-Butenoic acid, 4,4-difluoro-3-methyl- is its molecular structure, which incorporates two fluorine atoms at the 4-position and a methyl group at the 3-position. This configuration not only influences its physical properties, such as boiling point and solubility, but also its chemical behavior in reactions like nucleophilic substitution and Michael addition. Fluorinated compounds, in general, are highly sought after in drug discovery due to their ability to improve metabolic stability and bioavailability, a topic frequently searched in pharmaceutical research forums and databases.

In the pharmaceutical industry, CAS No. 2169795-24-6 is often utilized as a building block for the synthesis of more complex molecules. Its role in the development of small-molecule inhibitors and biologically active compounds has been highlighted in several recent studies. For instance, fluorinated analogs are known to enhance the binding affinity of drug candidates to target proteins, a feature that is critical in the design of next-generation therapeutics. This aligns with the growing demand for precision medicine and targeted drug delivery systems, which are hot topics in both academic and industrial research.

Beyond pharmaceuticals, 2-Butenoic acid, 4,4-difluoro-3-methyl- finds applications in the agrochemical sector. Fluorinated compounds are widely used in the development of crop protection agents due to their ability to resist degradation and improve efficacy. As the agricultural industry faces increasing pressure to adopt sustainable pest control methods, the demand for innovative chemical solutions like this compound is expected to rise. Searches for eco-friendly agrochemicals and fluorine in agriculture have spiked in recent years, reflecting this trend.

The synthesis and handling of 2-Butenoic acid, 4,4-difluoro-3-methyl- require specialized knowledge, particularly in organofluorine chemistry. Laboratories working with this compound often employ advanced techniques such as flow chemistry and catalyzed reactions to optimize yield and reduce waste. These methods are part of a broader movement toward process intensification, a concept frequently discussed in chemical engineering circles. Additionally, the compound's stability under various conditions makes it a candidate for high-throughput screening applications, another area of growing interest.

From a commercial perspective, the market for fluorinated organic compounds like CAS No. 2169795-24-6 is expanding rapidly. Analysts attribute this growth to the increasing adoption of fluorinated molecules in electronics and advanced materials. For example, fluorinated polymers derived from similar precursors are used in flexible displays and energy storage devices, sectors that are booming due to the rise of renewable energy technologies. This connection to cutting-edge applications further underscores the compound's relevance in modern chemistry.

In conclusion, 2-Butenoic acid, 4,4-difluoro-3-methyl- (CAS No. 2169795-24-6) represents a compelling example of how fluorinated compounds are driving innovation across multiple industries. Its applications in drug development, agriculture, and material science highlight its versatility, while its alignment with sustainability goals ensures its continued relevance. As research into fluorinated molecules advances, this compound is poised to play an even greater role in addressing some of the most pressing challenges in science and technology today.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)